Genetic study of fibrosing mediastinitis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033425

Enrollment

Unknown

Registered

2020-05-31

Start date

2020-06-01

Completion date

Unknown

Last updated

2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibrosing mediastinitis

Interventions

case series:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) CTPA suggests fibrosing mediastinitis in a patient. (2) Aged 18-80 years.

Exclusion criteria

Exclusion criteria: (1) Patients with pulmonary tumor, mediastinal or hilar metastatic tumor, suspected mediastinal necrotizing granulomatous lymphadenitis, systemic sclerosis and other manifestations of intramediastinal tissue hyperplasia (2) Lymphoma, Castleman's disease (3) Patients with cognitive impairment

Design outcomes

Primary

Measure	Time frame
CTPA;6-minute walk distance;WHO functional class;WHO functional class;	—

Secondary

Measure	Time frame
NT-proBNP;mean pulmonary arterial pressure;Cardiac Output;blood gas analysis;	—

Countries

China

Contacts

Public ContactYunshan Cao

Gansu Provincial Hospital

yunshancao@126.com+86 13669306699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026